Association between ischemia-modified albumin, homocysteine, vitamin B 12 and folic acid in patients with severe sepsis

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 8, 2012, Pages 1417-1421

  Erdem, Said Sami ^a   Yerlikaya, Fatma Hümeyra ^b   Çiçekler, Hümeyra ^a   Gül, Mehmet ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b University of Konya   (Turkey)

Author keywords

Folic acid; Homocysteine; Ischemia modified albumin; Sepsis; Vitamin B 12

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; ISCHEMIA MODIFIED ALBUMIN; MALONALDEHYDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEPSIS; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; SERUM ALBUMIN; VITAMIN B 12; YOUNG ADULT;

EID: 84867820771     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2011-0794     Document Type: Article

References (32)

1. Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 2006;48:28-54.
2. Tsantes A, Tsangaris I, Nikolopoulos G, Bagos P, Kopterides P, Antonakos G, et al. The effect of homocysteine on the clinical outcomes of ventilated patients with severe sepsis. Minerva Anestesiol 2010;76:787-94.
3. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-8.
4. Marshall JC, Cook DJ, Christou N V, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52.
5. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. J Am Med Assoc 1995;273:117-23.
6. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. J Am Med Assoc 1995;274:968-74.
7. Bar-Or D, Lau E, Winkler J V. A novel assay for cobalt-albumin binding and its potential as marker its potential as a marker for myocardial ischemia-A preliminary report. J Emer Med 2000;19:311-5.
8. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes-review and clinical implications. Clin Chem Lab Med 2011;49:177-84.
9. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006;92:113-4.
10. Valle Gottlieb MG, Da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, et al. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocr Metab 2010;95:586-91.
11. Kaefer M, Piva SJ, De Carvalho JA, Da Silva DB, Becker AM, Coelho AC, et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem 2010;43:450-4.
12. Kalita J, Kumar G, Bansal V, Misra UK. Relationship of homocysteine with other risk factors and outcome of ischemic stroke. Clin Neurol Neurosur 2009;111:364-7.
13. Vrentzos G, Papadakis JA, Malliaraki N, Zacharis EA, Katsogridakis K, Margioris AN. Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort. Angiology 2004;55:517-24.
14. Gallistl S, Sudi K, Mangge H, Erwa W, Borkenstein M. Insulin is a independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care 2000;23:1348-52.
15. Hirsch S, Poniachick J, Avendaño M, Csendes A, Burdiles P, Smok G, et al. Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. Nutrition 2005;21:137-41.
16. Pajares MA, Corrales F, Durán C, Mato JM, Alvarez L. How is rat liver S-adenosylmethionine synthetase regulated? FEBS Lett 1992;309:1-4.
17. Schroecksnadel K, Frick B, Winkler C, Leblhuber F, Wirleitner B, Fuchs D. Hyperhomocysteinemia and immune activation. Clin Chem Lab Med 2003;41:1438-43.
18. Ploder M, Kurz K, Spittler A, Neurauter G, Roth E, Fuchs D. Early increase of plasma homocysteine in sepsis patients with poor outcome. Mol Med 2010;16:498-504.
19. Matot I, Sprung CL. Definition of sepsis. Intensive Care Med 2001;27:3-9.
20. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Standardization of ischaemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 2007;45:261-2.
21. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990;186:421-31.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
23. Prauchner CA, Prestes Ade S, Da Rocha JB. Effects of diphenyl diselenide on oxidative stress induced by sepsis in rats. Pathol Res Pract 2011;207:554-8.
24. Alonso De Vega JM, Díaz J, Serrano E, Carbonell LF. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002;30:1782-6.
25. Heyman SN, Rosen S, Rosenberger C. A role for oxidative stress. Contrib Nephrol 2011;174:138-48.
26. Edwards SW, Hallett MB, Campbell AK. Oxygen-radical production during inflammation may be limited by oxygen concentration. Biochem J 1984;217:851-4.
27. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997;43:1209-14.
28. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001;50:756-60.
29. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009;42:666-71.
30. Kamezaki F, Yamashita K, Kubara T, Suzuki Y, Tanaka S, Rkouzuma R, et al. Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein. J Atheroscler Thromb 2008;15:206-12.
31. Ubbink JB, Vermaak WJ, Van Der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53.
32. Woodside J V, Yarnell JG, McMaster D, Young IS, Harmon DL, McCrum EE, et al. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial design, controlled trial. Am J Clin Nutr 1998;67:858-66.